Racial and ethnic differences in medications for opioid use disorder and overdose in 11 state Medicaid programs from 2016 to 2020

By afschroeder • March 7, 2026

Donohue J, Wang B, Tang L, Kim JY, Junker S, Cole E, Chang CH, Roberts E, Wilson JD, Essien U, Gifford K, Hammerslag L, Talbert J, Ahrens K, Idala D, Mohamoud S, Clark S, Austin A, Ware O, Tossone K, Mack A, Fry C, Gordon AJ, Barnes A, Marks S, Cunningham P, Allen L, Burns M, Kennedy S. Racial and ethnic differences in medications for opioid use disorder and overdose in 11 state Medicaid programs from 2016 to 2020. J Subst Use Addict Treat. 2026 Mar 4:209924. doi: 10.1016/j.josat.2026.209924. Epub ahead of print. PMID: 41791553.

Tags: buprenorphine, General Internal Medicine, medicaid, Medication for opioid-use disorder, methadone, naltrexone, Overdose, Publications, Racial/ethnic differences, Veterans Administration

Japan’s global health engagement in the Western Pacific: diagnosing structural inertia and a framework for human security diplomacy

Sakamoto H, Yamasaki L, Abe SK, Ezoe S, Egawa S, Guinto RR, Hashimoto H, Igarashi A, Lekagul A, Lwin KS, Mukaigawara M, Namkoong H, Nishino[...]

Short-interval coronary plaque remodeling assessed by serial AI-quantified coronary CTA during intensive plaque-directed therapy

Karlsberg RP, Thummala AR, Elisarraras FX, Golub IS, Cho GW. Short-interval coronary plaque remodeling assessed by serial AI-quantified coronary CTA during intensive plaque-directed therapy. J[...]

A Case of Gastrointestinal Krukenberg Tumor Initially Suspected as Primary Ovarian Cancer and the Implications for Management

Sidhu N, Le BM, Doan EL, Dao KT, Montana W. A Case of Gastrointestinal Krukenberg Tumor Initially Suspected as Primary Ovarian Cancer and the Implications[...]